0001681622-19-000059.txt : 20190715 0001681622-19-000059.hdr.sgml : 20190715 20190712175642 ACCESSION NUMBER: 0001681622-19-000059 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190711 ITEM INFORMATION: Cost Associated with Exit or Disposal Activities ITEM INFORMATION: Material Impairments FILED AS OF DATE: 20190715 DATE AS OF CHANGE: 20190712 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Varex Imaging Corp CENTRAL INDEX KEY: 0001681622 STANDARD INDUSTRIAL CLASSIFICATION: ELECTRONIC COMPONENTS, NEC [3679] IRS NUMBER: 813434516 STATE OF INCORPORATION: DE FISCAL YEAR END: 0927 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-37860 FILM NUMBER: 19953723 BUSINESS ADDRESS: STREET 1: 1678 S. PIONEER ROAD CITY: SALT LAKE CITY STATE: UT ZIP: 84104 BUSINESS PHONE: 801-972-5000 MAIL ADDRESS: STREET 1: 1678 S. PIONEER ROAD CITY: SALT LAKE CITY STATE: UT ZIP: 84104 8-K 1 a8-kcoverx71119santaclarad.htm 8-K Document


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
  ____________________________________________________
FORM 8-K
  ____________________________________________________
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): July 11, 2019
   ____________________________________________________
VAREX IMAGING CORPORATION
(Exact name of registrant as specified in its charter)
  ____________________________________________________
Delaware
(State or Other Jurisdiction of Incorporation)
 
001-37860
 
81-3434516
(Commission File Number)
 
(IRS Employer
Identification No.)

1678 S. Pioneer Road, Salt Lake City, Utah
 
84104
(Address of principal executive offices)
 
(Zip Code)
Registrant’s telephone number, including area code: (801) 972-5000
Not Applicable
(Former name or former address, if changed since last report)
 ____________________________________________________
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below): 
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
 
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
 
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
 
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock
VREX
The Nasdaq Global Select Market

 Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b - 2 of the Securities Exchange Act of 1934. Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐




Item 2.05
Costs Associated with Exit or Disposal Activities

On July 11, 2019, after receiving approval of the Board of Directors of Varex Imaging Corporation (the “Company”), management committed to closing the Company’s Santa Clara facility.  The closure of the Company's Santa Clara facility is being taken in connection with the ongoing integration of the imaging business acquired from PerkinElmer, Inc. in May 2017 and we expect operations at the Santa Clara facility to cease by the end of December 2020. Due to the closure of the Santa Clara facility, the Company anticipates the elimination of approximately 110 positions at the Santa Clara facility. The Company anticipates that all activities related to the closure of the Santa Clara facility will be completed by the end of March 2021.

The total amount of restructuring charges is expected to be in the range of $20 to $24 million, including approximately $6 million of accelerated depreciation, $6 to $7 million for the impairment of assets, $5 to $7 million for employee and severance related costs and $3 to $4 million for the remaining lease obligations.  The Company expects that approximately $8 to $11 million of these restructuring charges will result in future cash expenditures. The Company expects that the closure of the Santa Clara facility will deliver approximately $12 to $16 million in annual cost savings.

Item 2.06
Material Impairments

The information set forth above in Item 2.05 is incorporated by reference into this Item 2.06.




SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


 
 
VAREX IMAGING CORPORATION
 
 
 
Dated: July 12, 2019
By:
/s/ Kimberley E. Honeysett
 
 
Kimberley E. Honeysett
 
 
Senior Vice President, General Counsel and Corporate Secretary